4.5 Article

A new contingent screening strategy increased detection rate of trisomy 21 in the first trimester

Journal

BMC PREGNANCY AND CHILDBIRTH
Volume 23, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12884-023-06115-1

Keywords

Trisomy 21; Serum biochemical screening; First-trimester screening; Non-invasive prenatal screening; Prenatal diagnosis; Contingent screening strategy

Ask authors/readers for more resources

The study aims to increase the detection rate of trisomy 21 by defining appropriate cut-off values of serum biochemical markers and developing a sequential prenatal testing strategy associated with first-trimester screening. The results demonstrate that the new contingent screening strategy has a higher detection rate compared to the traditional strategy.
BackgroundAlthough the traditional contingent screening strategy is effective, there are still undetected low-risk trisomy 21. This study aims to define appropriate cut-off values of serum biochemical markers at low-risk and develop a strategy for sequential prenatal testing associated with first-trimester screening to increase the detection rate of trisomy 21.MethodsThis was a 9-year retrospective analysis of singleton pregnant women who underwent serum biochemical screening or combined first-trimester screening (CFTS) in the first trimester. For the low-risk group, the cut-off values of the serum biochemical markers were adjusted to determine the appropriate detection efficiency. Gravidas with abnormal serum biochemical markers at low-risk were advised to undergo further non-invasive prenatal screening (NIPS), whereas others continued with routine prenatal care.ResultsWhen cut-off values of free beta subunit of human chorionic gonadotropin (free beta-hCG) multiples of the median (MoM) or pregnancy-associated plasma protein A (PAPP-A) MoM were defined with >= 2.75 or <= 0.5, 7.72% (2,194/28,405) in the serum biochemical screening group and 12.36% (4,005/32,403) in CFTS group could be detected as abnormal results for further NIPS. Finally, 55.56% (5/9) and 85.71% (6/7) of trisomy 21 cases with false-negative results were detected, and the overall detection rate for trisomy 21 was improved by 10.64% (5/47) and 12.77% (6/47), respectively.ConclusionsThe new contingent screening strategy can increase the detection rate of trisomy 21 compared with the traditional contingent screening strategy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available